The Prognostic Significance of Tryptophanyl-tRNA Synthetase in Colorectal Cancer

被引:59
|
作者
Ghanipour, Arezo [1 ]
Jirstrom, Karin [4 ,5 ]
Ponten, Fredrik [2 ]
Glimelius, Bengt [3 ,6 ]
Pahlman, Lars [1 ]
Birgisson, Helgi [1 ]
机构
[1] Uppsala Univ, Dept Surg, Uppsala, Sweden
[2] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden
[3] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden
[4] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Ctr Mol Pathol, Malmo, Sweden
[5] Lund Univ, CREATE Hlth Ctr Translat Canc Res, Lund, Sweden
[6] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden
关键词
ENDOTHELIAL GROWTH-FACTOR; HUMAN PROTEIN ATLAS; TISSUE MICROARRAYS; FACTOR EXPRESSION; TUMOR-MARKERS; COLON-CANCER; VEGF-C; ANGIOGENESIS; FRAGMENT; THERAPY;
D O I
10.1158/1055-9965.EPI-09-0456
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Tryptophanyl-tRNA synthetase (TrpRS) is an aminoacyl-tRNA synthetase involved in protein synthesis and regulation of RNA transcription and translation and is an inhibitor of angiogenesis. TrpRS has been shown to be differentially expressed in colorectal cancer (CRC) and has thus been identified as a potential prognostic marker. The aim of this study was to analyze the correlation of TrpRS to the prognosis of patients diagnosed and treated for CRC within a defined population. Methods: With a polyclonal, monospecific IgG antibody, TrpRS expression was assessed by immunohistochemistry on tissue microarrays with tumors from a population-based CRC cohort (n = 320). Staining intensity and fraction of positive tumor cells were recorded. A Cox multivariate model including TrpRS expression, carcinoembryonic antigen, age, stage, tumor differentiation, and lymphatic and vascular vessel invasion was used to calculate the hazard ratio and 95% confidence interval (95% CI) for time to recurrence, disease-free survival, and overall survival. Results: Low expression of TrpRS correlated to increased risk for lymph node metastasis (P = 0.025) and a more advanced tumor stage (P = 0.001). Patients with tumors and increased levels of TrpRS expression had better survival than patients with low expression levels. Multivariate analyses revealed significantly better disease-free survival (relative risk, 0.59; 95% CI, 0.38-0.95) for patients with high expression than for patients with low expression of TrpRS. For colon cancer patients, a reduced risk for recurrence was seen in patients with increased TrpRS expression (relative risk, 0.23; 95% CI, 0.07-0.80). Conclusion: Low expression of TrpRS in tumor tissue correlates with increased risk for recurrence and worse survival in patients with CRC. This can be related to its antiangiogenic properties and could aid in the future selection of new drugs in the treatment of CRC. (Cancer Epidemiol Biomarkers Prev 2009;18(11):2949-56)
引用
收藏
页码:2949 / 2956
页数:8
相关论文
共 50 条
  • [41] Alternative splicing of 5'-terminal exons in human tryptophanyl-tRNA synthetase gene
    Sokolova, IV
    Narovlyanskii, AN
    Amchenkova, AM
    Turpaev, KT
    MOLECULAR BIOLOGY, 1996, 30 (02) : 185 - 192
  • [42] Unique roles of tryptophanyl-tRNA synthetase in immune control and its therapeutic implications
    Mirim Jin
    Experimental & Molecular Medicine, 2019, 51 : 1 - 10
  • [43] Human tryptophanyl-tRNA synthetase is an IFN-γ-inducible entry factor for Enterovirus
    Yeung, Man Lung
    Jia, Lilong
    Yip, Cyril C. Y.
    Chan, Jasper F. W.
    Teng, Jade L. L.
    Chan, Kwok-Hung
    Cai, Jian-Piao
    Zhang, Chaoyu
    Zhang, Anna J.
    Wong, Wan-Man
    Kok, Kin-Hang
    Lau, Susanna K. P.
    Woo, Patrick C. Y.
    Lo, Janice Y. C.
    Jin, Dong-Yan
    Shih, Shin-Ru
    Yuen, Kwok-Yung
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (11): : 5163 - 5177
  • [44] Matrix metalloproteinases inactivate the proinflammatory functions of secreted moonlighting tryptophanyl-tRNA synthetase
    Jobin, Parker G.
    Solis, Nestor
    Machado, Yoan
    Bell, Peter A.
    Kwon, Nam Hoon
    Kim, Sunghoon
    Overall, Christopher M.
    Butler, Georgina S.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (35) : 12866 - 12879
  • [45] An Appended Domain Results in an Unusual Architecture for Malaria Parasite Tryptophanyl-tRNA Synthetase
    Khan, Sameena
    Garg, Ankur
    Sharma, Arvind
    Camacho, Noelia
    Picchioni, Daria
    Saint-Leger, Adelaide
    Ribas de Pouplana, Lluis
    Yogavel, Manickam
    Sharma, Amit
    PLOS ONE, 2013, 8 (06):
  • [46] Computational studies of tryptophanyl-tRNA synthetase: Activation of ATP by induced-fit
    Kapustina, Maryna
    Carter, Charles W., Jr.
    JOURNAL OF MOLECULAR BIOLOGY, 2006, 362 (05) : 1159 - 1180
  • [47] Pseudorabies virus manipulates mitochondrial tryptophanyl-tRNA synthetase 2 for viral replication
    Li, Xiu-Qing
    Cai, Meng-Pan
    Wang, Ming-Yang
    Shi, Bo-Wen
    Yang, Guo-Yu
    Wang, Jiang
    Chu, Bei-Bei
    Ming, Sheng-Li
    VIROLOGICA SINICA, 2024, 39 (03) : 403 - 413
  • [48] A PREDICTIVE VALUE OF TRYPTOPHANYL-TRNA SYNTHETASE ON THE MORTALITY IN INTENSIVE CARE UNIT PATIENTS
    Yoon, Bo Ra
    Seol, Chang Hwan
    Leem, Ah Young
    Song, Joo Han
    Park, Moo Suk
    Kim, Young Sam
    Chung, Kyung Soo
    RESPIROLOGY, 2018, 23 : 23 - 23
  • [49] Unique roles of tryptophanyl-tRNA synthetase in immune control and its therapeutic implications
    Jin, Mirim
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 51 (1): : 1 - 10
  • [50] Full Implementation of the Genetic Code by Tryptophanyl-tRNA Synthetase Requires Intermodular Coupling
    Li, Li
    Carter, Charles W., Jr.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (48) : 34736 - 34745